Marsh & McLennan Companies Inc (MRSH) Stock Analysis
Verdict: HOLD
Deeply oversold blue-chip leader trading at a rare PEG-based discount as insurance pricing cycles peak, creating a high-margin entry floor.
Investment score: 64/100
Analysis as of
Is Marsh & McLennan Companies Inc stock worth reviewing? The TradeMates thesis
MMC is a best-in-class risk manager currently being punished for a cyclical cooling in insurance pricing. The model identifies this as a valuation-driven entry point.
7-factor investment score
- Valuation: 78/100 (weight 20%)
- Financial Health: 65/100 (weight 15%)
- Technical Momentum: 35/100 (weight 15%)
- Earnings Quality: 70/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 75/100 (weight 10%)
- Risk-Adjusted Return: 70/100 (weight 15%)
Marsh & McLennan Companies Inc opportunities and risks
What speaks for MRSH
- Valuation Arbitrage vs Peers
What speaks against MRSH
- End of the Insurance Pricing Cycle
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| MRSH | 19.9x | 2.8x | 14.8x | 42.4% | 14.3% | 6.3% |
| AJG | 31.5x | 3.4x | 12.9x | 66.0% | 10.8% | 3.7% |
| BRO | 16.0x | 2.9x | 11.9x | 59.4% | 17.9% | 7.9% |
| RYAN | 30.6x | 1.3x | 9.5x | 82.9% | 4.2% | 13.8% |
| HGTY | 28.5x | 2.5x | 27.7x | 78.0% | 2.6% | 4.7% |
| BWIN | n/a | 0.9x | 52.2x | 24.2% | -2.8% | -1.0% |
| Peer median | 28.5x | 2.5x | 12.9x | 66.0% | 4.2% | 4.7% |
Frequently asked questions about Marsh & McLennan Companies Inc (MRSH)
Is MRSH stock a good investment?
The TradeMates model rates Marsh & McLennan Companies Inc as HOLD with an investment score of 64/100. MMC is a best-in-class risk manager currently being punished for a cyclical cooling in insurance pricing. The model identifies this as a valuation-driven entry point. This is algorithmic model output, not personal investment advice.
Is MRSH stock a buy?
The TradeMates model verdict for MRSH is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.